KAVI

Fresenius Kabi is a global healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company's extensive portfolio includes intravenous generic drugs, infusion therapies, clinical nutrition products, and medical devices used to treat critically and chronically ill patients. In recent years, Fresenius Kabi has significantly expanded its presence in the biotechnology sector through its Biopharmaceuticals division, focusing on the development and commercialization of biosimilars in oncology and autoimmune diseases. With a global workforce of over 40,000 employees, the company operates as a key subsidiary of the Fresenius SE & Co. KGaA group, maintaining a robust manufacturing and supply chain network across Europe, North America, and Asia.